- Home
- LCFY vs NURO Comparison
LCFY vs NURO Comparison
Compare LCFY & NURO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LCFY
- NURO
- Stock Information
- Founded
- LCFY 2009
- NURO 1996
- Country
- LCFY Australia
- NURO United States
- Employees
- LCFY N/A
- NURO N/A
- Industry
- LCFY
- NURO Medical/Dental Instruments
- Sector
- LCFY
- NURO Health Care
- Exchange
- LCFY Nasdaq
- NURO Nasdaq
- Market Cap
- LCFY 7.3M
- NURO 7.6M
- IPO Year
- LCFY 2022
- NURO N/A
- Fundamental
- Price
- LCFY $6.30
- NURO $3.93
- Analyst Decision
- LCFY
- NURO
- Analyst Count
- LCFY 0
- NURO 0
- Target Price
- LCFY N/A
- NURO N/A
- AVG Volume (30 Days)
- LCFY 19.2K
- NURO 21.2K
- Earning Date
- LCFY 11-12-2024
- NURO 11-05-2024
- Dividend Yield
- LCFY N/A
- NURO N/A
- EPS Growth
- LCFY N/A
- NURO N/A
- EPS
- LCFY N/A
- NURO N/A
- Revenue
- LCFY $3,169,582.00
- NURO $3,767,764.00
- Revenue This Year
- LCFY N/A
- NURO N/A
- Revenue Next Year
- LCFY N/A
- NURO N/A
- P/E Ratio
- LCFY N/A
- NURO N/A
- Revenue Growth
- LCFY N/A
- NURO N/A
- 52 Week Low
- LCFY $2.20
- NURO $2.66
- 52 Week High
- LCFY $11.23
- NURO $4.73
- Technical
- Relative Strength Index (RSI)
- LCFY 63.67
- NURO 45.39
- Support Level
- LCFY $5.54
- NURO $3.56
- Resistance Level
- LCFY $7.99
- NURO $3.80
- Average True Range (ATR)
- LCFY 0.39
- NURO 0.30
- MACD
- LCFY 0.17
- NURO -0.03
- Stochastic Oscillator
- LCFY 61.62
- NURO 37.75
About LCFY Locafy Limited
Locafy Ltd is focused on commercializing its Software as a Service (SaaS) online publishing technology platform. Its platform enables the ability to publish almost any type of content to almost any device that uses a web browser to display web content. The firm has three operating segments: the Publishing segment, the Reseller segment, and the Channel sales segment. It derives a majority of its revenue from Australia and New Zealand.
About NURO NeuroMetrix Inc.
NeuroMetrix Inc is a commercial-stage healthcare company. Its core business activities are integrated with in-house capabilities spanning product development, manufacturing, regulatory affairs and compliance, sales and marketing, and customer support. The company produces bioelectrical and digital medicine to address chronic health conditions including chronic pain, sleep disorders, and diabetes. The product line of the company includes Wearable neuro-stimulation therapeutic devices and Point-of-care neuropathy diagnostic tests. The company operates in a single segment being Medical equipment and consumables.